Effects of interleukin-12/23 inhibitors and interleukin-17 inhibitors on myocardial functions in patients with severe psoriasis
Background and Design: Systemic inflammation, which is involved in the pathogenesis of psoriasis, has been associated with the development of systemic diseases such as metabolic syndrome and cardiovascular disease. Without prospective data, the relationship between biological therapies and myocardia...
Saved in:
Main Authors: | Leyla Baykal Selçuk, Mursel Şahin, Burcu Aydemir, Deniz Aksu Arıca, Savaş Yaylı |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2024-12-01
|
Series: | Turkderm Turkish Archives of Dermatology and Venereology |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=turkderm&un=TURKDERM-20737 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study – IL PSO (Italian landscape psoriasis)
by: Mario Valenti, et al.
Published: (2025-12-01) -
Shaping Treatment Expectation to Optimize Efficacy of Interleukin 17A Antagonist Secukinumab in Psoriasis Patients
by: Hölsken S, et al.
Published: (2025-01-01) -
Effect of Narrow Band Ultraviolet B Therapy versus Methotrexate on Serum Levels of Interleukin-17 and Interleukin-23 in Egyptian Patients with Severe Psoriasis
by: Tarek Mahmoud Elghandour, et al.
Published: (2013-01-01) -
Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study
by: Federico Diotallevi, et al.
Published: (2025-01-01) -
Interleukin-10 exhibit dose-dependent effects on macrophage phenotypes and cardiac remodeling after myocardial infarction
by: Jing J. Zhang, et al.
Published: (2025-01-01)